Alemtuzumab and CHOP in T-cell Lymphoma - No Study Results Posted

Alemtuzumab and CHOP in T-cell Lymphoma (ACT-1)

This study is currently recruiting participants.

Study NCT00646854 Information provided by University of Aarhus

First Received: February 14, 2008 Last Updated: September 29, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	February 2014
Estimated Primary Completion Date:	February 2012 (Final data collection date for primary outcome measure)